| |||||||||

Revenue by Geography (USD) Annual | ||||||||
|---|---|---|---|---|---|---|---|---|
| FISCAL YEAR ENDING |
|
31-DEC 2004 |
31-DEC 2005 |
31-DEC 2006 |
31-DEC 2007 |
31-DEC 2008 |
||
| Revenue - Latin America | 2.03B | 2.31B | 2.42B | 2.84B | 0 | |||
| Revenue - International | 19.7B | 22.7B | 22.5B | 25.3B | 27.9B | |||
| Revenue - US | 29.5B | 24.7B | 25.8B | 23.2B | 0 | |||
| Total Revenue | 52.5B | 51.3B | 48.4B | 48.4B | 48.3B | |||
Revenue by Segment (USD) Annual | ||||||||
|---|---|---|---|---|---|---|---|---|
| FISCAL YEAR ENDING |
|
31-DEC 2004 |
31-DEC 2005 |
31-DEC 2006 |
31-DEC 2007 |
31-DEC 2008 |
||
| Revenue - Animal Health | 0 | 0 | 0 | 2.31B | 2.83B | |||
| Revenue - Lipitor | 0 | 0 | 0 | 0 | 12.4B | |||
| Revenue - Norvasc | 0 | 0 | 0 | 0 | 2.24B | |||
| Revenue - Chantix/Champix | 0 | 0 | 0 | 0 | 846M | |||
| Revenue - Caduet | 0 | 0 | 0 | 0 | 589M | |||
| Revenue - Cardura | 0 | 0 | 0 | 0 | 499M | |||
| Revenue - Geodon/Zeldox | 0 | 0 | 0 | 0 | 1.01B | |||
| Revenue - Zoloft | 0 | 0 | 0 | 0 | 539M | |||
| Revenue - Aricept | 0 | 0 | 0 | 0 | 482M | |||
| Revenue - Neurontin | 0 | 0 | 0 | 0 | 387M | |||
| Revenue - Xanax/Xanax XR | 0 | 0 | 0 | 0 | 350M | |||
| Revenue - Relpax | 0 | 0 | 0 | 0 | 321M | |||
| Revenue - Celebrex | 0 | 0 | 0 | 0 | 2.49B | |||
| Revenue - Zyvox | 0 | 0 | 0 | 0 | 1.11B | |||
| Revenue - Vfend | 0 | 0 | 0 | 0 | 743M | |||
| Revenue - Zithromax/Zmax | 0 | 0 | 0 | 0 | 429M | |||
| Revenue - Diflucan | 0 | 0 | 0 | 0 | 373M | |||
| Revenue - Viagra | 0 | 0 | 0 | 0 | 1.93B | |||
| Revenue - Detrol/Detrol LA | 0 | 0 | 0 | 0 | 1.21B | |||
| Revenue - Sutent | 0 | 0 | 0 | 0 | 847M | |||
| Revenue - Camptosar | 0 | 0 | 0 | 0 | 563M | |||
| Revenue - Aromasin | 0 | 0 | 0 | 0 | 465M | |||
| Revenue - Xalatan/Xalacom | 0 | 0 | 0 | 0 | 1.75B | |||
| Revenue - Genotropin | 0 | 0 | 0 | 0 | 898M | |||
| Revenue - Zyrtec/Zyrtec D | 0 | 0 | 0 | 0 | 129M | |||
| Total Revenue | 52.5B | 51.3B | 48.4B | 48.4B | 48.3B | |||
| ||||||